Debopam Samanta

High Impact

Professor

UAMS

Also affiliated: Boston Children's Hospital (2022); Arkansas Children's Hospital (2016–2026); Nationwide Children's Hospital (2022); University of Arkansas Medical Center (2015–2026); Stanford Medicine (2022); University of Virginia (2013); The Ohio State University (2022); Stanford University (2022)

Peds Pediatrics, College of Medicine

27 h-index 217 pubs 2,351 cited

Research Areas

Biomedical Subjects

Links

ORCID Research Group UAMS TRI Profile

OverviewAI-generated summary

Debopam Samanta's research focuses on neurological disorders in children, with a particular emphasis on epilepsy. His work involves comprehensive reviews of various epilepsy syndromes, including PCDH19-related epilepsy, Lennox-Gastaut syndrome, and DEPDC5-related epilepsy. Samanta also investigates treatment modalities, such as the efficacy and safety of cannabidiol in epilepsy management, and explores barriers to and strategies for improving access to epilepsy surgery.

His scholarship includes a significant body of work on the underutilization of epilepsy surgery and the management of complex epilepsy conditions beyond childhood. Samanta's research group actively contributes to the understanding and treatment of these conditions. He has published over 200 articles, accumulating more than 2,200 citations, and holds an h-index of 26, indicating a substantial impact in his field. He is recognized as a highly cited researcher.

Metrics

h-index: 27
Publications: 217
Citations: 2,351

Positions

Professor publications 2014–2026

University of Arkansas for Medical Sciences Peds Pediatrics, College of Medicine Institutional directory
University of Arkansas for Medical Sciences publications 2014–2026

ORCID

Selected Publications

Early infantile developmental and epileptic encephalopathy: clinical spectrum, diagnosis, outcomes, and evolving treatment strategies (2026)

Brain and Development DOI OpenAlex
Developmental and/or Epileptic Encephalopathy with Spike-Wave Activation in Sleep: From Thalamocortical Mechanisms to Precision Therapy (2026)

Children DOI OpenAlex
Epilepsy of infancy with migrating focal seizures in <scp>RARS2</scp> ‐related disease: Expanding the clinical spectrum (2026)

Epileptic Disorders DOI OpenAlex
Epilepsy of infancy with migrating focal seizures: A scoping review of clinical features, diagnostic testing including genetics, long-term outcomes, mortality, and current and emerging therapeutic strategies (2026)

Epilepsy & Behavior 2 citations DOI OpenAlex
Delayed Surgical Evaluation After Drug-Resistant Epilepsy Diagnosis Worsens Outcomes in Children (2026)

Neurology Clinical Practice DOI OpenAlex
From synaptic dysfunction to targeted intervention: a comprehensive review of STXBP1 encephalopathy and precision therapeutic strategies (2026)

Epilepsy & Behavior 1 citation DOI OpenAlex
A systematic review of highly purified cannabidiol in developmental and epileptic encephalopathies and complex treatment-resistant epilepsies: Nonseizure outcomes (2026)

Epilepsy Research DOI OpenAlex
Responsive neurostimulation in pediatric drug-resistant epilepsy: A systematic review and meta-analysis of seizure and non-seizure outcomes, safety, and predictors of response (2026)

Seizure DOI OpenAlex
Targeted Treatments for Genetic Epilepsies, Part 1: Channelopathies (2026)

Current Treatment Options in Neurology DOI OpenAlex
Diagnosis and management guidelines for infantile epileptic spasms syndrome around the world: A scoping review and comparative study of international approaches (2026)

Epilepsia DOI OpenAlex
How I treat Angelman syndrome: an expert opinion (2026)

Expert Opinion on Pharmacotherapy DOI OpenAlex
First-Line Rituximab in Pediatric-Onset Multiple Sclerosis: Clinical and MRI Outcomes in a Retrospective Cohort (2026)

DOI OpenAlex
Photosensitive infantile spasms in a preterm infant with 4q22.3–q24 deletion involving <i>PPP3CA</i> (2026)

Epileptic Disorders DOI OpenAlex
SYNGAP1-related disorder: pathophysiology, epilepsy, cognitive and behavioral phenotypes, and precision therapeutic approaches (2026)

Epilepsy & Behavior 2 citations DOI OpenAlex
Reversible Pulmonary Arterial Hypertension Due to Fenfluramine in a Young Child: A Case Report (2026)

Cureus DOI OpenAlex

View all publications on OpenAlex →

Grants & Funding

As listed on this researcher's institutional profile.

GR039174-Samanta-TRI Masters Award UAMS ACHRI Flow Through Principal Investigator
Magnetoencephalography based tracking of fetal neurodevelopment in diabetic pregnancies NIH/Nat. Inst. of Child Health & Human Development Co-Investigator